Skye Bioscience, Inc. Increase Decrease In Operating Lease Liability
Skye Bioscience, Inc. (SKYE) reported Increase Decrease In Operating Lease Liability of -$237.95 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- Skye Bioscience, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$25.28K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$212.67K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$48.20K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$45.70K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for fiscal 2025 was -$181.94K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for fiscal 2024 was -$94.44K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for fiscal 2023 was -$76.57K.
- Skye Bioscience, Inc. increase decrease in operating lease liability for fiscal 2022 was -$82.37K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$237.95K 10-Q · filed 2026-08-14 | -$286.15K derived: sum of 3 quarters · filed 2026-08-14 | -$331.84K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$212.67K 10-Q · filed 2026-05-11 | -$260.87K derived: sum of 2 quarters · filed 2026-05-11 | -$306.56K derived: sum of 3 quarters · filed 2026-05-11 | -$351.13K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$48.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$93.89K derived: sum of 2 quarters · filed 2026-03-10 | -$138.47K derived: sum of 3 quarters · filed 2026-08-14 | -$181.94K 10-K · filed 2026-03-10 |
| 2025-09-30 | -$45.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$90.27K derived: sum of 2 quarters · filed 2026-08-14 | -$133.75K 10-Q · filed 2025-11-10 | -$175.91K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$44.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$88.05K 10-Q · filed 2026-08-14 | -$130.22K derived: sum of 3 quarters · filed 2026-08-14 | -$148.30K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$43.48K 10-Q · filed 2026-05-11 | -$85.65K derived: sum of 2 quarters · filed 2026-05-11 | -$103.72K derived: sum of 3 quarters · filed 2026-05-11 | -$121.14K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$42.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$60.25K derived: sum of 2 quarters · filed 2026-03-10 | -$77.66K derived: sum of 3 quarters · filed 2026-03-10 | -$94.44K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$18.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$35.49K derived: sum of 2 quarters · filed 2025-11-10 | -$52.27K 10-Q · filed 2025-11-10 | -$68.19K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$17.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$34.20K 10-Q · filed 2025-08-07 | -$50.12K derived: sum of 3 quarters · filed 2025-08-07 | -$64.97K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$16.78K 10-Q · filed 2025-05-08 | -$32.70K derived: sum of 2 quarters · filed 2025-05-08 | -$47.55K derived: sum of 3 quarters · filed 2025-05-08 | -$95.96K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$15.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$30.77K derived: sum of 2 quarters · filed 2025-03-20 | -$79.18K derived: sum of 3 quarters · filed 2025-03-20 | -$76.57K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$14.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$63.27K derived: sum of 2 quarters · filed 2024-11-07 | -$60.65K 10-Q · filed 2024-11-07 | -$82.53K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$48.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$45.79K 10-Q · filed 2024-08-09 | -$67.68K derived: sum of 3 quarters · filed 2024-08-09 | -$88.44K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $2.62K 10-Q · filed 2024-05-10 | -$19.27K derived: sum of 2 quarters · filed 2024-05-10 | -$40.03K derived: sum of 3 quarters · filed 2024-05-10 | -$60.19K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$21.88K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$42.65K derived: sum of 2 quarters · filed 2024-03-22 | -$62.81K derived: sum of 3 quarters · filed 2024-03-22 | -$82.37K 10-K · filed 2024-03-22 |
| 2022-09-30 | -$20.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$40.92K derived: sum of 2 quarters · filed 2023-11-14 | -$60.49K 10-Q · filed 2023-11-14 | -$63.58K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$20.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$39.72K 10-Q · filed 2023-08-07 | -$42.81K derived: sum of 3 quarters · filed 2023-08-07 | -$49.26K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$19.57K 10-Q · filed 2023-05-12 | -$22.66K derived: sum of 2 quarters · filed 2023-05-12 | -$29.10K derived: sum of 3 quarters · filed 2023-05-12 | -$29.10K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$3.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$9.53K derived: sum of 2 quarters · filed 2023-03-31 | -$9.53K derived: sum of 3 quarters · filed 2023-03-31 | -$9.53K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$6.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.44K derived: sum of 2 quarters · filed 2022-11-14 | -$6.44K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |